FrontierLab
A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

RadNet, Inc. RDNT

Weak   broader-coverage candidate · RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad

On FrontierLab's discovery record since 2026-07-06 (13 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Weak" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-09-23), not the curated Frontier signal.

Key quality signals

Revenue growth (YoY)18.9%
Gross margin9.7%
Gross profits / assets0.05
Rule of 4022.9
Net margin4%
Cash runway (months)—
PEG—
Price / sales2.6

Quality checklist

Fundamentals — snapshot as of 2026-09-23

StageEstablished
Share issuance (YoY)6.3% · heavy issuance
Moat—
TAM—
P/E (trailing)—
EPS (trailing)$-0.27
Burn multiple—
Gross-margin trend (pts)-1.9
Cash / assets0.17
Net debt / EBITDA4.3
Statements as ofQ2 FY2026 · filed 2026-08-10

Momentum context — a snapshot from 2026-09-23, not current

Price at surface$73.93 (as of 2026-09-23)
52-week range$50.82 – $85.84
% off 52-wk high-13.9%
RSI (14)50
Relative volume1×

Risk flags

Thin gross margin — keeps little of each sales dollar (judge it against its industry).Heavy share dilution (>5%/yr) — your slice shrinks.

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-09-23 (end-of-day). How grades are computed →